關於「ONTARGET trial」標籤，搜尋引擎有相關的訊息討論：

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular ...。

2008年4月10日 · The ONTARGET Investigators. The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) investigators ...。

Full Text View - ClinicalTrials.gov。

The Ongoing Telmisartan Alone and combination with Ramipril global Endpoint trial (ONTARGET). Time to first event analysis of the endpoint non-fatal stroke.。

ONTARGET still OFF-TARGET? | Circulation - aha journals。

2011年2月28日 · Alternatively, the population enrolled in the ONTARGET trial or the ... Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, ...： tw | tw。

ONgoing Telmisartan Alone and in combination with Ramipril Global ...。

ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial - ONTARGET. Sep 15, 2008. Share via: AddThis Sharing Buttons.： 。

The ONTARGET/TRANSCEND Trial Programme: baseline data。

Cardiovascular risk is determined by multiple risk factors, all of which greatly increase the chance of morbidity and mortality. So-called "normal" levels ...： 。

Results of the ONTARGET and TRANSCEND studies - NCBI。

2009年4月8日 · Clinical trials in hypertension and heart failure suggested the angiotensin receptor blockers (ARB) might have the vascular protective benefits ...： 。

Safety and Efficacy of Low Blood Pressures Among Patients With ...。

2012年1月3日 · The recently published ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) (15) provides an ...。

Antihypertensive therapy and progression of nondiabetic chronic ...。

Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA ...。

Dual renin-angiotensin system inhibition for prevention of renal and ...。

2013年7月19日 · The ONTARGET® study, the largest trial of dual RAS inhibition in ... Doulton TW, He FJ, MacGregor GA: Systematic review of combined ...。

Recent Advances in the Pathogenesis, Prevention and Management of ...。

[114] Sowers JR, Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC ... into hypertension guidelines: the case of the ONTARGET and TRANSCEND trials.